Does PRP Contain HIV?
Autologous PRP (prepared from a patient's own blood) cannot transmit HIV to that same patient, but PRP prepared from HIV-infected blood will contain the virus if the donor is infected. The critical safety distinction is between autologous (self-donated) versus allogeneic (donor) preparations, and whether proper infection control procedures are followed during preparation and administration.
Key Safety Principles
Autologous PRP
When PRP is prepared from a patient's own blood and immediately used for that same patient, there is no risk of HIV transmission because the patient already has their own HIV status 1. The guidelines emphasize that autologous PRP is prepared from anticoagulated blood collected at the time of therapeutic application 1.
The Real Risk: Contamination During Preparation
The documented risk of HIV transmission with PRP occurs through improper infection control practices, not from the plasma itself in autologous use. A critical 2024 CDC investigation identified an HIV cluster among clients who received PRP microneedling facials at an unlicensed spa facility 2. This outbreak resulted from:
- Failure to follow recommended infection control procedures
- Lack of proper sterilization between patients
- Cross-contamination via unsterile injection practices
- No maintenance of client records for traceback
Nucleotide sequence analysis revealed highly similar HIV strains among all cases, confirming transmission occurred at the facility 2.
HIV and Platelets: The Science
Research demonstrates that:
- Platelets can bind and internalize HIV particles through endocytic vacuoles and the open canalicular system, particularly when platelets are activated 3
- HIV particles have been identified within platelets using electron microscopy and immunogold labeling for viral core protein p24 3
- However, this does not mean autologous PRP transmits HIV to the same patient—it means if someone is HIV-positive, their platelets may contain virus
Allogeneic (Donor) PRP Considerations
While rare, allogeneic PRP from single donors is mentioned in guidelines 1. One case report documented that platelet donations collected very early after HIV infection (Day 4) and testing negative did not transmit HIV to recipients 4. However, this represents the eclipse period before viral RNA detection and should not be interpreted as safety assurance.
Clinical Recommendations
Mandatory Safety Practices
All PRP procedures must incorporate rigorous infection prevention protocols 5:
- Product labeling and documentation following blood product regulatory standards
- Single-use, sterile equipment for each patient
- Proper centrifugation protocols in controlled environments
- Aseptic technique throughout preparation and injection
- Healthcare personnel training on bloodborne pathogen exposure prevention
Contraindications and Precautions
Recent 2025 consensus recommendations address infectious disease considerations 6:
- Active viral infections require careful evaluation
- Immunosuppressive therapy status must be assessed
- The key is not whether PRP "contains" HIV in autologous use, but whether the preparation and administration environment prevents cross-contamination
Facility Requirements
PRP should only be administered in licensed facilities that:
- Maintain proper infection control standards
- Keep detailed client/patient records
- Use FDA-cleared or properly validated centrifugation systems
- Follow blood product handling regulations 2, 5
Common Pitfalls to Avoid
Unlicensed facilities: The 2024 outbreak occurred at an unlicensed spa—avoid any facility not meeting healthcare standards 2
Reuse of equipment: Never allow reuse of needles, syringes, or any equipment between patients
Inadequate training: Ensure providers understand PRP is classified as a blood product with specific handling requirements 5
Poor documentation: Facilities must maintain records for traceback in case of adverse events 2